Number of Shares
12.48 Mil
Current Holdings Value*
$125.92 Mil
% of Portfolio
52.09%
Total Estimate Gain
$52.17 Mil
% of Total Estimate Gain
56.23%

Patient Square Capital LP's Roivant Sciences Ltd Holding Summary

As of 2025-03-31, Patient Square Capital LP held 12.48 Mil shares of Roivant Sciences Ltd(ROIV), totaling $125.92 Mil. This investment constitutes 52.09% of their stock portfolio, and Patient Square Capital LP now holds 1.75% of the outstanding Roivant Sciences Ltd(ROIV) stock.

The initial trade took place in 2022Q4. And since then Patient Square Capital LP has made 2 purchases of ROIV, at an average price of $7.20, for a total of 12.89 Mil shares. In addition, there have been 1 sales at an average price of $10.78 for 411,455.00 shares. Based on historical transaction data and ROIV's current price of $11.26, Patient Square Capital LP's estimated gain on his ROIV holdings is $52.17 Mil, reflecting a 56.23% gain to date.

Patient Square Capital LP ROIV ($11.26) Holding Chart

Patient Square Capital LP ROIV ($11.26) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1